ApoGraft for the Prevention of Acute Graft Versus Host Disease in Haploidentical Hematopoietic Cell Transplant Recipients

NCT04006652 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Lost funding

Conditions

Acute Graft Versus Host Disease
Haploidentical Hematopoietic Stem Cell Transplant

Interventions

DRUG: ApoGraft

Sponsor

Washington University School of Medicine

Collaborators

[object Object]